Market Research Logo

Global Non-Small Cell Lung Cancer Market and Competitive Landscape – 2017

Global Non-Small Cell Lung Cancer Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Non-Small Cell Lung Cancer Market and Competitive Landscape – 2017, provides comprehensive insights into Non-Small Cell Lung Cancer pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Non-Small Cell Lung Cancer market size and drug sales. This research also provides insights into Non-Small Cell Lung Cancer epidemiology and late stage pipeline.
The report is classified into twelve sections – Non-Small Cell Lung Cancer overview with definitions, symptoms, etiology, diagnosis, treatment options; Non-Small Cell Lung Cancer pipeline insights covering late stage clinical trials pipeline; Non-Small Cell Lung Cancer prevalence trends by countries; Non-Small Cell Lung Cancer market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

  • Non-Small Cell Lung Cancer pipeline: Find out the drugs in clinical trials for Non-Small Cell Lung Cancer by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Non-Small Cell Lung Cancer epidemiology: Find out the prevalence of Non-Small Cell Lung Cancer by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Non-Small Cell Lung Cancer products: Identify key products marketed and prescribed for Non-Small Cell Lung Cancer by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Non-Small Cell Lung Cancer market size: Find out the market size for Non-Small Cell Lung Cancer drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Non-Small Cell Lung Cancer drug sales: Find out the sales of Non-Small Cell Lung Cancer drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Non-Small Cell Lung Cancer drugs sales forecast: Sales forecast for Non-Small Cell Lung Cancer drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Non-Small Cell Lung Cancer market share analysis: Find out the market shares of Non-Small Cell Lung Cancer drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Non-Small Cell Lung Cancer drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Non-Small Cell Lung Cancer market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Non-Small Cell Lung Cancer market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Non-Small Cell Lung Cancer: Disease Overview
1.1. Non-Small Cell Lung Cancer Symptoms
1.2. Non-Small Cell Lung Cancer Etiology
1.3. Non-Small Cell Lung Cancer Diagnosis
1.4. Non-Small Cell Lung Cancer Treatment Options
2. Non-Small Cell Lung Cancer Pipeline Insights
2.1. Non-Small Cell Lung Cancer Phase 3 Clinical Trials
2.2. Non-Small Cell Lung Cancer Phase 2 Clinical Trials
2.3. Non-Small Cell Lung Cancer Phase 1 Clinical Trials
3. Non-Small Cell Lung Cancer Epidemiology Analysis
4. US Non-Small Cell Lung Cancer Market Insights
4.1. Marketed Products for Non-Small Cell Lung Cancer in US
4.2. US Non-Small Cell Lung Cancer Market Size & Forecast
4.3. US Non-Small Cell Lung Cancer Product Sales Forecast
4.4. US Non-Small Cell Lung Cancer Market Share Analysis
5. Germany Non-Small Cell Lung Cancer Market Insights
5.1. Marketed Products for Non-Small Cell Lung Cancer in Germany
5.2. Germany Non-Small Cell Lung Cancer Market Size & Forecast
5.3. Germany Non-Small Cell Lung Cancer Product Sales Forecast
5.4. Germany Non-Small Cell Lung Cancer Market Share Analysis
6. France Non-Small Cell Lung Cancer Market Insights
6.1. Marketed Products for Non-Small Cell Lung Cancer in France
6.2. France Non-Small Cell Lung Cancer Market Size & Forecast
6.3. France Non-Small Cell Lung Cancer Product Sales Forecast
6.4. France Non-Small Cell Lung Cancer Market Share Analysis
7. Italy Non-Small Cell Lung Cancer Market Insights
7.1. Marketed Products for Non-Small Cell Lung Cancer in Italy
7.2. Italy Non-Small Cell Lung Cancer Market Size & Forecast
7.3. Italy Non-Small Cell Lung Cancer Product Sales Forecast
7.4. Italy Non-Small Cell Lung Cancer Market Share Analysis
8. Spain Non-Small Cell Lung Cancer Market Insights
8.1. Marketed Products for Non-Small Cell Lung Cancer in Spain
8.2. Spain Non-Small Cell Lung Cancer Market Size & Forecast
8.3. Spain Non-Small Cell Lung Cancer Product Sales Forecast
8.4. Spain Non-Small Cell Lung Cancer Market Share Analysis
9. UK Non-Small Cell Lung Cancer Market Insights
9.1. Marketed Products for Non-Small Cell Lung Cancer in UK
9.2. UK Non-Small Cell Lung Cancer Market Size & Forecast
9.3. UK Non-Small Cell Lung Cancer Product Sales Forecast
9.4. UK Non-Small Cell Lung Cancer Market Share Analysis
10. Europe Non-Small Cell Lung Cancer Market Insights
10.1. Europe Non-Small Cell Lung Cancer Market Size & Forecast
10.2. Europe Non-Small Cell Lung Cancer Product Sales Forecast
10.3. Europe Non-Small Cell Lung Cancer Market Share Analysis
11. Japan Non-Small Cell Lung Cancer Market Insights
11.1. Marketed Products for Non-Small Cell Lung Cancer in Japan
11.2. Japan Non-Small Cell Lung Cancer Market Size & Forecast
11.3. Japan Non-Small Cell Lung Cancer Product Sales Forecast
11.4. Japan Non-Small Cell Lung Cancer Market Share Analysis
12. Global Non-Small Cell Lung Cancer Market Insights
12.1. Global Non-Small Cell Lung Cancer Market Size & Forecast
12.2. Global Non-Small Cell Lung Cancer Product Sales Forecast
12.3. Global Non-Small Cell Lung Cancer Market Share Analysis
13. Research Methodology
LIST OF TABLES
Table 1: Non-Small Cell Lung Cancer Phase 3 Clinical Trials, Global, 2017
Table 2: Non-Small Cell Lung Cancer Phase 2 Clinical Trials, Global, 2017
Table 3: Non-Small Cell Lung Cancer Phase 1 Clinical Trials, Global, 2017
Table 4: Non-Small Cell Lung Cancer Prevalence by G7 Countries, 2012 - 2021
Table 5: Marketed Products for Non-Small Cell Lung Cancer in US, 2017
Table 6: US Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 7: US Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Table 8: US Non-Small Cell Lung Cancer Market Trends, 2012 - 2021
Table 9: Marketed Products for Non-Small Cell Lung Cancer in Germany, 2017
Table 10: Germany Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 11: Germany Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Table 12: Germany Non-Small Cell Lung Cancer Market Trends, 2012 - 2021
Table 13: Marketed Products for Non-Small Cell Lung Cancer in France, 2017
Table 14: France Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 15: France Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Table 16: France Non-Small Cell Lung Cancer Market Trends, 2012 - 2021
Table 17: Marketed Products for Non-Small Cell Lung Cancer in Italy, 2017
Table 18: Italy Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 19: Italy Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Table 20: Italy Non-Small Cell Lung Cancer Market Trends, 2012 - 2021
Table 21: Marketed Products for Non-Small Cell Lung Cancer in Spain, 2017
Table 22: Spain Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 23: Spain Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Table 24: Spain Non-Small Cell Lung Cancer Market Trends, 2012 - 2021
Table 25: Marketed Products for Non-Small Cell Lung Cancer in UK, 2017
Table 26: UK Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 27: UK Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Table 28: UK Non-Small Cell Lung Cancer Market Trends, 2012 - 2021
Table 29: Europe Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 30: Europe Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Table 31: Marketed Products for Non-Small Cell Lung Cancer in Japan, 2017
Table 32: Japan Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 33: Japan Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Table 34: Japan Non-Small Cell Lung Cancer Market Trends, 2012 - 2021
Table 35: Global Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 36: Global Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Non-Small Cell Lung Cancer Pipeline by Phase (%), Global, 2017
Figure 2: Non-Small Cell Lung Cancer Prevalence by G7 Countries, 2012 - 2021
Figure 3: US Non-Small Cell Lung Cancer Market Size ($mn), 2012 - 2021
Figure 4: US Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Figure 5: US Non-Small Cell Lung Cancer Market Share by Products (%), 2016
Figure 6: US Non-Small Cell Lung Cancer Market - Future Market Share (%), 2021
Figure 7: Germany Non-Small Cell Lung Cancer Market Size ($mn), 2012 - 2021
Figure 8: Germany Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Figure 9: Germany Non-Small Cell Lung Cancer Market Share by Products (%), 2016
Figure 10: Germany Non-Small Cell Lung Cancer Market - Future Market Share (%), 2021
Figure 11: France Non-Small Cell Lung Cancer Market Size ($mn), 2012 - 2021
Figure 12: France Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Figure 13: France Non-Small Cell Lung Cancer Market Share by Products (%), 2016
Figure 14: France Non-Small Cell Lung Cancer Market - Future Market Share (%), 2021
Figure 15: Italy Non-Small Cell Lung Cancer Market Size ($mn), 2012 - 2021
Figure 16: Italy Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Figure 17: Italy Non-Small Cell Lung Cancer Market Share by Products (%), 2016
Figure 18: Italy Non-Small Cell Lung Cancer Market - Future Market Share (%), 2021
Figure 19: Spain Non-Small Cell Lung Cancer Market Size ($mn), 2012 - 2021
Figure 20: Spain Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Figure 21: Spain Non-Small Cell Lung Cancer Market Share by Products (%), 2016
Figure 22: Spain Non-Small Cell Lung Cancer Market - Future Market Share (%), 2021
Figure 23: UK Non-Small Cell Lung Cancer Market Size ($mn), 2012 - 2021
Figure 24: UK Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Figure 25: UK Non-Small Cell Lung Cancer Market Share by Products (%), 2016
Figure 26: UK Non-Small Cell Lung Cancer Market - Future Market Share (%), 2021
Figure 27: Europe Non-Small Cell Lung Cancer Market Size ($mn), 2012 - 2021
Figure 28: Europe Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Figure 29: Europe Non-Small Cell Lung Cancer Market Share by Products (%), 2016
Figure 30: Europe Non-Small Cell Lung Cancer Market - Future Market Share (%), 2021
Figure 31: Japan Non-Small Cell Lung Cancer Market Size ($mn), 2012 - 2021
Figure 32: Japan Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Figure 33: Japan Non-Small Cell Lung Cancer Market Share by Products (%), 2016
Figure 34: Japan Non-Small Cell Lung Cancer Market - Future Market Share (%), 2021
Figure 35: Global Non-Small Cell Lung Cancer Market Size ($mn), 2012 - 2021
Figure 36: Global Non-Small Cell Lung Cancer Product Sales ($mn), 2012 - 2021
Figure 37: Global Non-Small Cell Lung Cancer Market Share by Products (%), 2016
Figure 38: Global Non-Small Cell Lung Cancer Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report